Topics and Expertise: TRANSPERS

Initiative seeks to translate advances in precision medicine into changes in health care policy and practice

Every day, on average, ten new genetic tests become commercially available to help doctors and patients make more informed decisions about health care.

Kathryn Phillips, PhD, discusses insurance coverage for genomic testing in her recent articles published in JAMA and Science.

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...